ArticlePharmaceuticals (Basel, Switzerland)2022

Reversing Cardiac Hypertrophy at the Source Using a Cardiac Targeting Peptide Linked to miRNA106a: Targeting Genes That Cause Cardiac Hypertrophy.

G Ian Gallicano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.